Delos and Propstack enter into a collaboration to create healthy buildings across India

Propstack to promote Delos powered advanced air purification units across sectors to help improve health and well-being in indoor environments

The housing sector continues to experience an infusion of last-mile funding for project completion.

The housing sector continues to experience an infusion of last-mile funding for project completion.

To create a healthier and a safer office environment in a post COVID-19 environment, a wellness real estate and technology company Delos and Propstack, a real estate technology and data company, on June 21 entered into a strategic collaboration to advance health and well-being in India.

Through the collaboration, Propstack will introduce wellness technology in buildings through the adoption of Delos’ advanced air purification units to improve the quality of indoor environments across the country.

In response to the current pandemic, air purification systems have been considered by many to be a critical supplementary approach to reducing virus transmission rates by removing airborne pollutants and contaminants.

“After sustainability, there is a rise in demand for healthier buildings following the second wave of COVID-19. We realised that several real estate developers would want to rate their commercial buildings for wellness as employees start getting back to work,” said Raja Seetharaman, co-founder, Propstack.

“The opportunity in India is massive. Both existing and new buildings can benefit from these evidence-based solutions,” he said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“From more than eight years of experience and extensive research, we know that our indoor environments can play a significant role in safeguarding our health and well-being. We are proud to collaborate with Propstack to make our science-backed solutions more accessible in India and advance health and wellness across the country,” said Delos CEO and Founder Paul Scialla.

Earlier this year, Embassy REIT, India’s first listed REIT, subscribed to the WELL Portfolio programme by the International WELL Building Institute, another wellness rating, to create healthier office buildings.
Moneycontrol News
first published: Jun 21, 2021 05:47 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark